AbbVie Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $7.04B | $6.56B | $479.0M | $353.0M |
| FY2017 | $9.96B | $9.43B | $529.0M | $365.0M |
| FY2018 | $13.43B | $12.79B | $638.0M | $421.0M |
| FY2019 | $13.32B | $12.77B | $552.0M | $430.0M |
| FY2020 | $17.59B | $16.79B | $798.0M | $753.0M |
| FY2021 | $22.78B | $21.99B | $787.0M | $692.0M |
| FY2022 | $24.94B | $24.25B | $695.0M | $671.0M |
| FY2023 | $22.84B | $22.06B | $777.0M | $747.0M |
| FY2024 | $18.81B | $17.83B | $974.0M | $911.0M |
| FY2025 | $19.03B | $17.82B | $1.21B | $955.0M |